Renaud Leclère
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Renaud Leclère has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Coralie Guérin
Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg
22 shared publications - Sylvain Baulande
Institut Curie Genomics of Excellence (ICGex) Platform, PSL Research University, Institut Curie Research Center, Paris, France
22 shared publications - Agata Cieslak
Universite Paris Cite, Institut Necker-Enfants Malades (INEM), Institut national de la sante et de la recherche medicale (Inserm) U1151
21 shared publications - Agathe Seguin-Givelet
Institut Montsouris, Surgery Department, Institut du Thorax Curie Montsouris, Paris, France
21 shared publications - Alessio Mariolo
Curie-Montsouris Thoracic Institute Thoracic Surgery Department, Institut Mutualiste Montsouris Paris
21 shared publications - Alexandre Lanau
INSERM U830, Institut Curie, PSL Université, Paris, France
21 shared publications
Latest Publications
- Open Access
- 12 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer
Invasive lobular breast carcinoma (ILC) shows specific stromal features, and a high tumor-infiltrating lymphocyte (TIL) content being associated with poor patient prognosis. Here, we reveal the underlying mechanism by performing single-cell analysis, immunohistochemistry, deconvolution of bulk RNA-sequencing in a large female ILC series and functional assays. We show that E-cadherin (CDH1)-loss in breast cancer cells prevents differentiation of FAP+ inflammatory cancer-associated fibroblasts (iCAF) into FAP+ myofibroblastic CAF, leading to iCAF accumulation in ILC. In turn, FAP+ iCAF attract TILs into the tumor center, shaping their spatial organization. Subsequently, CDH1-inactivated ILC cancer cells promote immune escape through a lack of retention and activation of ITGAE-expressing resident memory CD8 + T lymphocytes (TRM). Hence, our study uncovers reciprocal interactions between CDH1-inactivated cancer cells, FAP+ iCAF and CD8 + TRM, providing insights into the ILC stromal reaction and revealing why and how TILs are associated with poor prognosis in ILC patients, a mechanism generalizable to other CDH1-inactivated cancer types.
- 12 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessE-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer
Invasive lobular breast carcinoma (ILC) shows specific stromal features, and a high tumor-infiltrating lymphocyte (TIL) content being associated with poor patient prognosis. Here, we reveal the underlying mechanism by performing single-cell analysis, immunohistochemistry, deconvolution of bulk RNA-sequencing in a large female ILC series and functional assays. We show that E-cadherin (CDH1)-loss in breast cancer cells prevents differentiation of FAP+ inflammatory cancer-associated fibroblasts (iCAF) into FAP+ myofibroblastic CAF, leading to iCAF accumulation in ILC. In turn, FAP+ iCAF attract TILs into the tumor center, shaping their spatial organization. Subsequently, CDH1-inactivated ILC cancer cells promote immune escape through a lack of retention and activation of ITGAE-expressing resident memory CD8 + T lymphocytes (TRM). Hence, our study uncovers reciprocal interactions between CDH1-inactivated cancer cells, FAP+ iCAF and CD8 + TRM, providing insights into the ILC stromal reaction and revealing why and how TILs are associated with poor prognosis in ILC patients, a mechanism generalizable to other CDH1-inactivated cancer types.
- Open Access
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S9. Gating strategy for sorting EPCAM+CD45- cells after TEC digestion
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S9. Gating strategy for sorting EPCAM+CD45- cells after TEC digestion
- Open Access
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S2. Quality control for T cells scRNA-seq
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S2. Quality control for T cells scRNA-seq
- Open Access
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Supp. Fig. S3. Filtering of Thymocytes dataset
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Supp. Fig. S3. Filtering of Thymocytes dataset
- Open Access
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S1. Gating strategy for the characterization of hematopoietic CD45+ cells (pediatric sample Ped4 shown as example).
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S1. Gating strategy for the characterization of hematopoietic CD45+ cells (pediatric sample Ped4 shown as example).
- Open Access
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Supplementary table S2D : Raw DEG of scRNA-seq from TEC
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Supplementary table S2D : Raw DEG of scRNA-seq from TEC
- Open Access
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Supplementary Table S5. Conditions for antibodies for the MICSSS (Multiplexed Immunohistochemical Consecutive Staining on Single Slide).
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Supplementary Table S5. Conditions for antibodies for the MICSSS (Multiplexed Immunohistochemical Consecutive Staining on Single Slide).
- Open Access
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Supplementary Table S3: Quality and chain metrics for scTCR-seq (paired with scRNA-seq)
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Supplementary Table S3: Quality and chain metrics for scTCR-seq (paired with scRNA-seq)
- Open Access
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S5. Description of most immature T cells precursors, Early Thymic Precursors (ETP) CD3-CD34+ cells from Alive DUMP-CD45+: CD3-CD34+ cells.
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S5. Description of most immature T cells precursors, Early Thymic Precursors (ETP) CD3-CD34+ cells from Alive DUMP-CD45+: CD3-CD34+ cells.
- Open Access
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 15 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S15. Expression of cytokines involved in thymocyte migration.
- 8 January 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 15 from Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance
Sup. Fig. S15. Expression of cytokines involved in thymocyte migration.